Rhoen Klinikum AG
Healthcare · EUR · XETRA
Price
€12.45
Cap
€961.58M
Earnings
—
30d Trend
+0.8%
23% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 46×Macro 0.99 (−1%)=46
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
Medium-term outlook is neutral — no clear directional thesis
BRAIN47'S ASSESSMENT
I rate Rhoen Klinikum AG at 46/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is risk management at 65/100. I classify this as a income position with the strongest thesis on a medium-term horizon.
PAST PERFORMANCE
1 MONTH
+1.6%
3 MONTHS
-3.8%
12 MONTHS
-2.3%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
Medium-term outlook is neutral — no clear directional thesis. low-risk profile and Momentum (48) are the primary strengths. I note that fundamentals is the weakest area at 34/100 — this warrants monitoring. Historical volatility is normal at 23%. I classify this as an income position — the 80.7% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.